Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Neoplasms × Methylphenidate × Clear all

Phase

Status

Sponsor Class

OTHER 6 INDUSTRY 1 FED 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Fatigue 1

Interventions

pembrolizumab 111 Paclitaxel 86 Gemcitabine 83 Carboplatin 72 Nivolumab 56 Docetaxel 54 Bevacizumab 54 Cisplatin 45 Pemetrexed 42 Fluorouracil 40 Cyclophosphamide 38 Cetuximab 32 Capecitabine 31 Leucovorin 30 venetoclax 29 Irinotecan 29 trametinib 28 atezolizumab 28 Sorafenib 28 Erlotinib Hydrochloride 26 Dexamethasone 25 130-nm albumin-bound paclitaxel 25 Drug Therapy 24 Ipilimumab 23 Epoetin Alfa 23 Doxorubicin 22 Prednisone 20 Oxaliplatin 20 Lapatinib 19 dabrafenib 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00758407 2010-01-13

EMF

Medice Arzneimittel Pütter GmbH & Co KG

Phase 2/3 Completed

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡